Cutting-Edge Solutions for VTE Prophylaxis and DVT Treatment.
Inhixia by Techdow
Solution for X-linked Hypophosphatemia (XLH)
CRYSViTA
- The body produces an excess of fibroblast growth factor 23 (FGF23).
- This excess FGF23 causes the kidneys to release too much phosphorus through the urine.
- The resulting low phosphorus levels can weaken bones.
Peripheral Blood Progenitor Cell Mobilization and Neupogen Treatment
Neupogen
























